Loading
Latest filing published 19 Jun 2017 for NexgenRx Inc..
No signal scores available.
Charles Burns appears in our data through filings on NexgenRx Inc. shares, published by SEDI. The record holds 2 filings, all for trades on 16 June 2017.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 19 June 2017, the filings show a transaction in NexgenRx Inc. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations